NZ624714A - Methods for treating gout in patient subpopulations - Google Patents
Methods for treating gout in patient subpopulationsInfo
- Publication number
- NZ624714A NZ624714A NZ624714A NZ62471411A NZ624714A NZ 624714 A NZ624714 A NZ 624714A NZ 624714 A NZ624714 A NZ 624714A NZ 62471411 A NZ62471411 A NZ 62471411A NZ 624714 A NZ624714 A NZ 624714A
- Authority
- NZ
- New Zealand
- Prior art keywords
- methods
- medicament
- treating gout
- renal function
- patient subpopulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/059425 WO2013066352A1 (en) | 2011-11-04 | 2011-11-04 | Methods for treating gout in patient subpopulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ624714A true NZ624714A (en) | 2016-01-29 |
Family
ID=48192536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ624714A NZ624714A (en) | 2011-11-04 | 2011-11-04 | Methods for treating gout in patient subpopulations |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2775835A4 (zh) |
| JP (1) | JP6047172B2 (zh) |
| KR (1) | KR101848122B1 (zh) |
| CN (1) | CN104066323A (zh) |
| AU (1) | AU2011380509B2 (zh) |
| BR (1) | BR112014010693A2 (zh) |
| CA (1) | CA2859689C (zh) |
| CL (1) | CL2014001156A1 (zh) |
| IL (1) | IL232385A (zh) |
| MX (1) | MX354846B (zh) |
| NZ (1) | NZ624714A (zh) |
| SG (1) | SG11201402027PA (zh) |
| WO (1) | WO2013066352A1 (zh) |
| ZA (1) | ZA201403574B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015512948A (ja) * | 2012-04-13 | 2015-04-30 | サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ハロフェナートまたはハロフェン酸および抗炎症剤を用いる痛風に罹っている患者の高尿酸血症の治療方法 |
| CN106036135A (zh) * | 2014-07-25 | 2016-10-26 | 许伟琦 | 一种防止结石、快速排结石的药物、组合物、兽药 |
| CN105920022A (zh) * | 2016-05-12 | 2016-09-07 | 成都易创思生物科技有限公司 | 一种抗痛风药物复方制剂 |
| JP7086980B2 (ja) * | 2017-10-26 | 2022-06-20 | 大塚製薬株式会社 | イノシトールリン酸含有組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4250191A (en) * | 1978-11-30 | 1981-02-10 | Edwards K David | Preventing renal failure |
| US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| CN103058944B (zh) * | 2007-11-27 | 2015-08-05 | 亚德生化公司 | 调节血液尿酸水平的化合物 |
-
2011
- 2011-11-04 AU AU2011380509A patent/AU2011380509B2/en not_active Ceased
- 2011-11-04 KR KR1020147015209A patent/KR101848122B1/ko active IP Right Grant
- 2011-11-04 CA CA2859689A patent/CA2859689C/en not_active Expired - Fee Related
- 2011-11-04 MX MX2014005399A patent/MX354846B/es active IP Right Grant
- 2011-11-04 NZ NZ624714A patent/NZ624714A/en not_active IP Right Cessation
- 2011-11-04 CN CN201180076189.7A patent/CN104066323A/zh active Pending
- 2011-11-04 EP EP11875027.2A patent/EP2775835A4/en not_active Withdrawn
- 2011-11-04 WO PCT/US2011/059425 patent/WO2013066352A1/en active Application Filing
- 2011-11-04 JP JP2014541012A patent/JP6047172B2/ja not_active Expired - Fee Related
- 2011-11-04 SG SG11201402027PA patent/SG11201402027PA/en unknown
- 2011-11-04 BR BR112014010693-2A patent/BR112014010693A2/pt not_active IP Right Cessation
-
2014
- 2014-04-30 IL IL232385A patent/IL232385A/en active IP Right Grant
- 2014-05-02 CL CL2014001156A patent/CL2014001156A1/es unknown
- 2014-05-16 ZA ZA2014/03574A patent/ZA201403574B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2859689A1 (en) | 2013-05-10 |
| AU2011380509A1 (en) | 2014-05-29 |
| CN104066323A (zh) | 2014-09-24 |
| KR101848122B1 (ko) | 2018-04-11 |
| ZA201403574B (en) | 2015-11-25 |
| MX2014005399A (es) | 2015-04-08 |
| JP2014532759A (ja) | 2014-12-08 |
| EP2775835A4 (en) | 2015-07-29 |
| IL232385A (en) | 2017-10-31 |
| IL232385A0 (en) | 2014-06-30 |
| CL2014001156A1 (es) | 2015-01-16 |
| WO2013066352A1 (en) | 2013-05-10 |
| BR112014010693A2 (pt) | 2020-11-10 |
| EP2775835A1 (en) | 2014-09-17 |
| KR20140123927A (ko) | 2014-10-23 |
| AU2011380509B2 (en) | 2016-05-19 |
| SG11201402027PA (en) | 2014-09-26 |
| MX354846B (es) | 2018-03-22 |
| JP6047172B2 (ja) | 2016-12-21 |
| CA2859689C (en) | 2018-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012081898A3 (ko) | 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법 | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| MX360634B (es) | Inhibidores de 3-haloalilamina sustituidos de ssao y uso de los mismos. | |
| EA201100440A1 (ru) | Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты | |
| IN2014MN02089A (zh) | ||
| UA115320C2 (uk) | Інгібітори кінази | |
| MX2020010004A (es) | Composicion farmaceutica que comprende empagliflozina, metodos para tratamiento y sus usos. | |
| MY174894A (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation | |
| MX363949B (es) | Inhibidor de quinasa. | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| MX2014005996A (es) | Anticuerpo anti - adrenomedulina (adm) o fragmento de anticuerpo anti - adm o un andamio no ig anti - adm para usarse en terapia. | |
| WO2014099633A3 (en) | Inhibitors of the renal outer medullary potassium channel | |
| MX2014006629A (es) | Inhibidores de cinasa. | |
| AU2011208681A8 (en) | Aqueous solution comprising 3 - quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease | |
| WO2015095097A3 (en) | Inhibitors of the renal outer medullary potassium channel | |
| EA201390335A1 (ru) | Введение лоркасерина индивидуумам с почечной недостаточностью | |
| EP3065734A4 (en) | Ferric citrate for reducing cardiac failure in chronic kidney disease patients | |
| MX2012009600A (es) | Metodo para estabilizar daño de articulacion en sujetos utilizando inhibidores de xantina oxidoreductasa. | |
| NZ624714A (en) | Methods for treating gout in patient subpopulations | |
| FR2961695B1 (fr) | Utilisation de composes dans le traitement ou la prevention de troubles cutanes | |
| MX2013014398A (es) | Derivados de sulfonamida heterociclicos. | |
| EA201190256A1 (ru) | Способ снижения уровня убиквитинилированных белков | |
| UA109359C2 (xx) | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
| NZ624708A (en) | Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent | |
| NZ702666A (en) | A method of weight reduction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 04 NOV 2018 BY AJ PARK Effective date: 20160726 |
|
| ASS | Change of ownership |
Owner name: CYMABAY THERAPEUTICS, INC., US Effective date: 20170309 Owner name: DIATEX, INC., NZ Effective date: 20170309 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 NOV 2019 BY CPA GLOBAL Effective date: 20180920 |
|
| LAPS | Patent lapsed |